Lisa Wilson | In-Site Communications, Investor Relations |
Nikhil Lalwani | President & Chief Executive Officer |
Stephen Carey | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
Elliot Wilbur | Raymond James |
Dana Flanders | Guggenheim |
Good morning, and welcome to today's program. My name is Maria, and I'll be your conference operator. At this time, I'd like to welcome everyone to ANI Pharmaceuticals Fourth Quarter and Year End 2020 Earnings Results and Business Update Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer period.